阿司匹林作为一种潜在的药物重新定位候选药物,在乳腺癌中准雌激素受体α:一个分子动力学和体外研究

相关实验视频

Updated: Jul 4, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.3K

Deepinder Kaur1, Chinmayee Choudhury1,2, Reena Yadav1

  • 1Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, India.

Journal of biomolecular structure & dynamics
|January 27, 2024
PubMed
概括

阿司匹林可以通过与其连接体结合域结合来抑制雌激素受体α (ERα),这可能为乳腺癌治疗提供一种新的策略,特别是在耐药病例中.

关键词:
乳腺癌是什么? 乳腺癌是什么这就是SERMs.激进分子的激进分子.它们是对手的对手.阿司匹林是一种阿司匹林.药物重用是为了改变药物的用途.雌激素受体阿尔法受体是什么分子对接的分子对接.分子动力学模拟的模拟.

更多相关视频

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.5K

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K